-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Guardant Health, Lowers Price Target to $190

Benzinga·11/10/2026 12:55:52
Listen to the news
Piper Sandler analyst David Westenberg maintains Guardant Health (NASDAQ:GH) with a Overweight and lowers the price target from $193 to $190.